AEON Biopharma (AEON) Registration filing summary

Management team and governance

• President and CEO is Robert Bancroft, who also serves as Principal Executive Officer and Director.

• Chief Accounting Officer is Jennifer Sy, serving as Principal Accounting Officer.

• Chief Financial Officer is John Bencich, serving as Principal Financial Officer.

• Board includes Jost Fischer (Chairman), Robert Palmisano, Shelley Thunen, Eric Carter, Seongsoo Park, and Marc Forth.

Offering details and pricing

• Registration statement filed for Class A common stock, $0.0001 par value per share.

• Five-Year Milestone Warrants registered at 115% of the assumed public offering price.

• Incremental registration fee paid for the increased aggregate offering price.

• Securities may be offered on a delayed or continuous basis under Rule 415.

Underwriters and syndicate

• Underwriting Agreement dated January 6, 2025, with Aegis Capital Corp.

• Sales Agreement dated August 14, 2024, with Leerink Partners LLC.